Coremed introduces improved drug-delivery insulin technology
Coremed has introduced its proprietary drug-delivery platform technology that improves absorption of certain proteins and macromolecules such as insulin within the gastrointestinal tract.
Archives for November 14, 2005
Pliva posts 9-month net loss of $34 million
Pliva released its financial results for the first nine months of 2005, which revealed a net loss of $34 million, as the drug maker tries to recover from its loss-making drug launch in the US. This is despite posting higher revenues of $282 million...
Pain Therapeutics and King Pharma enter opioid alliance
Pain Therapeutics and King Pharmaceuticals have entered into an alliance to develop and commercialise Remoxy in an alliance worth at least $400 million (€342 million). The deal positions the abuse-resistant opioid painkiller as a major new class of drug.
Pall reveals faster vaccine production method for avian flu
Pall Corporation has revealed a unique approach for speeding vaccine production, which could provide a solution to the potentially huge demand for vaccines by governments and pharmaceutical manufacturers in response to the avian flu crisis.
New excipient drives industry search for alternatives
Last month, In-PharmaTechnologist.com reported on Cargill-Cerestar's plans to unveil a new excipient at CPhI which is developed on the back of a directly compressible excipient platform allowing tablets to be produced using lower compression forces.